HBV - 2
•History:
•1982 -first vaccine made available for use
•purified suspension of inactivated HBV surface antigens
•antigen obtained from chronic HBsAg carriers
•Now -vaccine made from recombinant HBV antigen
•Indications for vaccination against HBV:
•ePre-exposure
•ePost-exposure
•ePerinatal exposure
•Žhealth care professionals
•Žthose at increased risk for exposure to HBV
•Žindividuals who have been exposed to body fluids of patient who has tested positive for HBV
•Žif mother tests positive for HBsAg at delivery, the newborn is treated same as post-exposure patient
Return